30 employees
Sernova develops regenerative medicine therapeutic technologies for treatment of chronic metabolic diseases.
2006
$4.2M
from 1 investors over 1 rounds
Sernova Corp. raised $4.2M on July 6, 2016
Investors: Gravitas Securities Inc.